SLC28A1 and neoplasm: 8 genes, namely LRP2, EPB41L4A, SLC6A3, FRMD3, PTGER3, ABI3BP, SLC28A1, and CIT showed over 2-fold changes in increased promoter accessibility and expression in Epi-H tumor clusters (Fig. 5d).